News, Events & Press


News

March 1, 2021 - News & Press

CeNTech GmbH: New CEO Enno Fuchs

As the new business developer of the City of Münster, Enno Fuchs will also take over the management of the CeNTech GmbH, the Technologieförderung GmbH and the NBZ GmbH. For the past eight years, he was the managing director of the Bochum Perspektive 2022 GmbH, thereby responsible for development and marketing of the areas formerly used by Opel. In addition, Enno Fuchs worked for the automotive group General Motors as head of the operation in Norway and was responsible for the e-mobility division at Opel Vauxhall. He has many years of national and international experience in management positions in the public sector, industry and technology area. In this context he is very pleased to take over CeNTech GmbH and in this way to support a future-oriented technology.

Read on

February 27, 2021 - News & Press

CeNTech GmbH: New chairwoman of the supervisory board

At the first meeting of the supervisory board after the local elections last fall, Babette Lichtenstein van Lengerich, member of the Münster City Councel, was unanimously elected as the new chairwoman of the CeNTech GmbH supervisory board. City Councilor Robert Wenzel takes over her representation.

Read on

Nov 27, 2020 - News & Press

New Collaborative Research Center (SFB) for Nanotechnology

The German research association (DFG) is going to fund the new Collaborative Research Center (SFB) "Intelligent Material: From Responsive to Adaptive Nanosystems". CeNTech Scientist Prof. Dr. Wolfram Pernice is deputy spokesman of the project. Such intelligent materials offer new perspectives, for example for the development of artificial skin.

Read on

Oct 10, 2020 - News & Press

COVID 19 Test system successfully refined

CeNTech initiated a transnational collaboration that lead to a successful refinement of a COVID 19 test System. The British company Eluceda, www.eluceda.com, is currently undergoing clinical validation of a new PCR free rapid test system for the virus SARS-CoV-2. As the company was unable to obtain suitable corona samples within the UK during lockdown, the EU project MATMED introduced and funded a collaboration with the German diagnostic company Carpegen GmbH, www.carpegen.de. The company from Münster provided corona samples and furthermore analyzed the sample using two different standard PCR procedures - Carpegen´s in-house SARS-CoV-2 assay and a commercial SARS-CoV-2 detection kit. The collaboration led to a significant acceleration of the technology readiness level of the corona test technology. For additional information about the MATMED voucher funding system click on www.matmed.eu.

Read on


<<  Seite 2 von 14  >>